InvestorsHub Logo
Followers 1015
Posts 39001
Boards Moderated 0
Alias Born 04/27/2015

Re: HNDRXX post# 10081

Monday, 08/10/2020 2:16:24 PM

Monday, August 10, 2020 2:16:24 PM

Post# of 63384
HNDRXX:

BRTXQ is emerging from a Cinderella like Bankruptcy Reorganization & Restructuring. Here is their reorganization plan posted on their website: http://www.biorestorative.com/plan-of-reorganization/

This company fell tooo low after their BK and the street walked away from them thinking they will never recover. Now the AUCTUS FUND LLC, who is a known penny stock investor did something they never did before and now Jointly and Physically fighting in court to save BRTXQ from BK
. They drafted up to 75 pages of restructuring plans going forward that was presented in court. They hired a top Attorney who specializes in bankruptcy reorganization and restructuring. https://www.murphyking.com/attorneys/william-r-moorman-jr/

We believe it is because BRTXQ already completed their FDA Phase 1 Stem Cell Trials but went broke and couldn't finish their Phase 2 trials. Now AUCTUS FUND LLC is bailing them out to make sure they can finish their Phase 2 Trials. Everything is clearly in favor of BRTXQ and AUCTUS Fund. It was also revealed this weekend that BRTXQ has an actual Stem Cell Drug & Device that will be injected into live humans during this trial. Hit products on their webpage and here is a description of the BRTX-100 Stem Cell Drug being used for FDA Phase 2 Trials: http://www.biorestorative.com/#products

I havent seen a OTCBB in years that have a actual drug product. An old school stock I remember was EPGL that ran from .0001 to 05+ on just a device and not the drug.
We wont see a play like this for years to come be cause it took years for us to see this one.

Also, Biorestorative Therapies September 2019 Isreal & Australia Patents For Metabolic Stem Cell Program:


https://www.otcmarkets.com/stock/BRTXQ/news/BioRestorative-Therapies-Receives-Patent-in-Israel-For-Its-Metabolic-Program?id=249195
https://www.otcmarkets.com/stock/BRTXQ/news/BioRestorative-Therapies-Receives-A-Second-Patent-in-Australia-For-Its-Metabolic-Program?id=244017

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRTX News